Arno Furquim d'Almeida onderzoeker

Publicaties Arno Furquim d'Almeida

A liver gene signature links liver cancer risk in chronic viral hepatitis to intrahepatic IgA plasma cells

Bron
JHEP Reports - ISSN 2589-5559-8:4 (2026) p. 1-11
Auteur(s)

Clinical trial : hepatitis B virus genotype and a combination of end‐of‐treatment biomarkers predict severe flares after nucleos(t)ide analogue cessation

Bron
Alimentary pharmacology and therapeutics - ISSN 0269-2813-63:3 (2026) p. 352-361
Auteur(s)
    Arno Furquim d'Almeida, Axelle Vanderlinden, Stefan Bourgeois, Jean‐Pierre Mulkay, Thomas Sersté, Mathieu Struyve, Baro Deressa, Dirk Sprengers, Marie de Vos, Jos Callens, Bao Shihao, Hendrik Reynaert, Pierre Deltenre, Filip Janssens, Sergio Negrin‐Dastis, Peter Stärkel, Hans Orlent, Guy Van Roey, Xavier Verhelst, Christophe Moreno, Jean Delwaide, Christophe Van Steenkiste, Wim Verlinden, Isabelle Colle, Marie‐Laure Plissonnier, Benoît Kabamba Mukadi, Barbara Testoni, Fabien Zoulim, Veerle Matheeussen, Thomas Vanwolleghem

Persistent risk of hepatocellular carcinoma despite improvement of liver stiffness in patients with chronic HBV with advanced fibrosis

Bron
JHEP Reports - ISSN 2589-5559-7:11 (2025) p. 1-9
Auteur(s)
    Lesley A. Patmore, Lilian Y. Liang, George Papatheodoridis, Mai Kilany, Arno Furquim d'Almeida, Vincent W.S. Wong, Margarita Papatheodoridi, Thomas Vanwolleghem, Pieter Honkoop, Hans Blokzijl, Ozgur M. Koc, Harry L.A. Janssen, Matthijs Kramer, Joep de Bruijne, Apichat Kaewdech, Robert A. de Man, R. Bart Takkenberg, Grace L.H. Wong, Jordan J. Feld, Milan J. Sonneveld

Severe liver‐related outcomes in patients with hepatitis delta : results from a multi‐ethnic multicenter long‐term follow‐up study

Bron
Journal of viral hepatitis - ISSN 1352-0504-32:2 (2025) p. 1-15
Auteur(s)